Loading…

Liposomal diclofenac eye drop formulations targeting the retina: Formulation stability improvement using surface modification of liposomes

The modifying liposome surface with polyvinyl alcohol or its derivative prevented the liposome aggregation and/or fusion during remote loading process, leading to effective retinal delivery. An efficient liposomal formulation for targeting the retina was produced as an optimal means of distributing...

Full description

Saved in:
Bibliographic Details
Published in:International journal of pharmaceutics 2012-10, Vol.436 (1-2), p.564-567
Main Authors: Fujisawa, Takuya, Miyai, Hiroko, Hironaka, Kohei, Tsukamoto, Toshimasa, Tahara, Kohei, Tozuka, Yuichi, Ito, Masaki, Takeuchi, Hirofumi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c455t-6f9d3442517c7b06f1d30317b7f0675bbb73c045088fb1026a805cc672fd84553
cites cdi_FETCH-LOGICAL-c455t-6f9d3442517c7b06f1d30317b7f0675bbb73c045088fb1026a805cc672fd84553
container_end_page 567
container_issue 1-2
container_start_page 564
container_title International journal of pharmaceutics
container_volume 436
creator Fujisawa, Takuya
Miyai, Hiroko
Hironaka, Kohei
Tsukamoto, Toshimasa
Tahara, Kohei
Tozuka, Yuichi
Ito, Masaki
Takeuchi, Hirofumi
description The modifying liposome surface with polyvinyl alcohol or its derivative prevented the liposome aggregation and/or fusion during remote loading process, leading to effective retinal delivery. An efficient liposomal formulation for targeting the retina was produced as an optimal means of distributing therapeutic agents to the retina. Diclofenac was used as a model compound for liposome encapsulation, and the release rate and distribution to the retina were investigated. The calcium acetate gradient method was found to be the optimal method for encapsulating diclofenac into liposomes. Entrapment efficiency using this method was greater than 97%, whereas conventional hydration method achieved 51.3%. The resultant formulation obtained with the gradient method caused aggregation and/or fusion of liposomes. To avoid inhibition of retinal delivery due to the aggregation of the carrier, surface modification was performed simultaneously with the gradient method. The increase in particle size of the liposomal formulation clearly was inhibited for a long time in the presence of polyvinyl alcohol or its derivative. This observation may be explained by surface modification of the liposomes by physisorption or anchoring effect of polymers on the surface of the lipid bilayer. Furthermore, the sustained release profile of the diclofenac formulation was retained after modification. An in vivo animal study revealed that concentration of the accumulated diclofenac in the retina–choroid was enhanced 1.8-fold by surface-modified liposome entrapment compared to that of the unaltered diclofenac solution.
doi_str_mv 10.1016/j.ijpharm.2012.07.024
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1037886259</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517312007272</els_id><sourcerecordid>1037886259</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-6f9d3442517c7b06f1d30317b7f0675bbb73c045088fb1026a805cc672fd84553</originalsourceid><addsrcrecordid>eNqFkc1u1DAcxC0EotvCIwA-cknwR_xRLqiqaEFaiQP0bDnO31uvkjjYSaV9BZ4aR1ngyMk-_GY8nkHoDSU1JVR-ONbhOD3aNNSMUFYTVRPWPEM7qhWveKPkc7QjXOlKUMUv0GXOR0KIZJS_RBeMaaaJYjv0ax-mmONge9wF10cPo3UYToC7FCfsYxqW3s4hjhnPNh1gDuMBz4-A03q1H_HdPwTn2bahD_MJh2FK8QkGGGe85FWTl-StAzzELvjgNkH0uN8CQH6FXnjbZ3h9Pq_Qw93nH7dfqv23-6-3N_vKNULMlfTXHW8aVv7lVEukpx0nnKpWeSKVaNtWcUcaQbT2LSVMWk2Ec1Ix3-niwK_Q-823JPy5QJ7NELKDvrcjxCUbutamJRPXBRUb6lLMOYE3UwqDTacCmXUGczTnGcw6gyHKlBmK7u35iaUdoPur-tN7Ad5tgLfR2EMK2Tx8Lw6CFBdBpS7Ep42AUsVTgGSyCzA66EICN5suhv-E-A2di6gQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1037886259</pqid></control><display><type>article</type><title>Liposomal diclofenac eye drop formulations targeting the retina: Formulation stability improvement using surface modification of liposomes</title><source>Elsevier</source><creator>Fujisawa, Takuya ; Miyai, Hiroko ; Hironaka, Kohei ; Tsukamoto, Toshimasa ; Tahara, Kohei ; Tozuka, Yuichi ; Ito, Masaki ; Takeuchi, Hirofumi</creator><creatorcontrib>Fujisawa, Takuya ; Miyai, Hiroko ; Hironaka, Kohei ; Tsukamoto, Toshimasa ; Tahara, Kohei ; Tozuka, Yuichi ; Ito, Masaki ; Takeuchi, Hirofumi</creatorcontrib><description>The modifying liposome surface with polyvinyl alcohol or its derivative prevented the liposome aggregation and/or fusion during remote loading process, leading to effective retinal delivery. An efficient liposomal formulation for targeting the retina was produced as an optimal means of distributing therapeutic agents to the retina. Diclofenac was used as a model compound for liposome encapsulation, and the release rate and distribution to the retina were investigated. The calcium acetate gradient method was found to be the optimal method for encapsulating diclofenac into liposomes. Entrapment efficiency using this method was greater than 97%, whereas conventional hydration method achieved 51.3%. The resultant formulation obtained with the gradient method caused aggregation and/or fusion of liposomes. To avoid inhibition of retinal delivery due to the aggregation of the carrier, surface modification was performed simultaneously with the gradient method. The increase in particle size of the liposomal formulation clearly was inhibited for a long time in the presence of polyvinyl alcohol or its derivative. This observation may be explained by surface modification of the liposomes by physisorption or anchoring effect of polymers on the surface of the lipid bilayer. Furthermore, the sustained release profile of the diclofenac formulation was retained after modification. An in vivo animal study revealed that concentration of the accumulated diclofenac in the retina–choroid was enhanced 1.8-fold by surface-modified liposome entrapment compared to that of the unaltered diclofenac solution.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2012.07.024</identifier><identifier>PMID: 22828072</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>acetates ; Animals ; Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage ; Anti-Inflammatory Agents, Non-Steroidal - chemistry ; Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics ; calcium ; Calcium acetate gradient method ; Chemistry, Pharmaceutical ; Diclofenac ; Diclofenac - administration &amp; dosage ; Diclofenac - chemistry ; Diclofenac - pharmacokinetics ; Drug Stability ; encapsulation ; Eye drop ; Liposome ; Liposomes ; Ophthalmic Solutions ; Particle Size ; polyvinyl alcohol ; Polyvinyl Alcohol - administration &amp; dosage ; Polyvinyl Alcohol - chemistry ; Polyvinyl Alcohol - pharmacokinetics ; PVA ; Rabbits ; Retina ; Retina - metabolism ; Surface Properties</subject><ispartof>International journal of pharmaceutics, 2012-10, Vol.436 (1-2), p.564-567</ispartof><rights>2012 Elsevier B.V.</rights><rights>Copyright © 2012 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-6f9d3442517c7b06f1d30317b7f0675bbb73c045088fb1026a805cc672fd84553</citedby><cites>FETCH-LOGICAL-c455t-6f9d3442517c7b06f1d30317b7f0675bbb73c045088fb1026a805cc672fd84553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22828072$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fujisawa, Takuya</creatorcontrib><creatorcontrib>Miyai, Hiroko</creatorcontrib><creatorcontrib>Hironaka, Kohei</creatorcontrib><creatorcontrib>Tsukamoto, Toshimasa</creatorcontrib><creatorcontrib>Tahara, Kohei</creatorcontrib><creatorcontrib>Tozuka, Yuichi</creatorcontrib><creatorcontrib>Ito, Masaki</creatorcontrib><creatorcontrib>Takeuchi, Hirofumi</creatorcontrib><title>Liposomal diclofenac eye drop formulations targeting the retina: Formulation stability improvement using surface modification of liposomes</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>The modifying liposome surface with polyvinyl alcohol or its derivative prevented the liposome aggregation and/or fusion during remote loading process, leading to effective retinal delivery. An efficient liposomal formulation for targeting the retina was produced as an optimal means of distributing therapeutic agents to the retina. Diclofenac was used as a model compound for liposome encapsulation, and the release rate and distribution to the retina were investigated. The calcium acetate gradient method was found to be the optimal method for encapsulating diclofenac into liposomes. Entrapment efficiency using this method was greater than 97%, whereas conventional hydration method achieved 51.3%. The resultant formulation obtained with the gradient method caused aggregation and/or fusion of liposomes. To avoid inhibition of retinal delivery due to the aggregation of the carrier, surface modification was performed simultaneously with the gradient method. The increase in particle size of the liposomal formulation clearly was inhibited for a long time in the presence of polyvinyl alcohol or its derivative. This observation may be explained by surface modification of the liposomes by physisorption or anchoring effect of polymers on the surface of the lipid bilayer. Furthermore, the sustained release profile of the diclofenac formulation was retained after modification. An in vivo animal study revealed that concentration of the accumulated diclofenac in the retina–choroid was enhanced 1.8-fold by surface-modified liposome entrapment compared to that of the unaltered diclofenac solution.</description><subject>acetates</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - chemistry</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics</subject><subject>calcium</subject><subject>Calcium acetate gradient method</subject><subject>Chemistry, Pharmaceutical</subject><subject>Diclofenac</subject><subject>Diclofenac - administration &amp; dosage</subject><subject>Diclofenac - chemistry</subject><subject>Diclofenac - pharmacokinetics</subject><subject>Drug Stability</subject><subject>encapsulation</subject><subject>Eye drop</subject><subject>Liposome</subject><subject>Liposomes</subject><subject>Ophthalmic Solutions</subject><subject>Particle Size</subject><subject>polyvinyl alcohol</subject><subject>Polyvinyl Alcohol - administration &amp; dosage</subject><subject>Polyvinyl Alcohol - chemistry</subject><subject>Polyvinyl Alcohol - pharmacokinetics</subject><subject>PVA</subject><subject>Rabbits</subject><subject>Retina</subject><subject>Retina - metabolism</subject><subject>Surface Properties</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqFkc1u1DAcxC0EotvCIwA-cknwR_xRLqiqaEFaiQP0bDnO31uvkjjYSaV9BZ4aR1ngyMk-_GY8nkHoDSU1JVR-ONbhOD3aNNSMUFYTVRPWPEM7qhWveKPkc7QjXOlKUMUv0GXOR0KIZJS_RBeMaaaJYjv0ax-mmONge9wF10cPo3UYToC7FCfsYxqW3s4hjhnPNh1gDuMBz4-A03q1H_HdPwTn2bahD_MJh2FK8QkGGGe85FWTl-StAzzELvjgNkH0uN8CQH6FXnjbZ3h9Pq_Qw93nH7dfqv23-6-3N_vKNULMlfTXHW8aVv7lVEukpx0nnKpWeSKVaNtWcUcaQbT2LSVMWk2Ec1Ix3-niwK_Q-823JPy5QJ7NELKDvrcjxCUbutamJRPXBRUb6lLMOYE3UwqDTacCmXUGczTnGcw6gyHKlBmK7u35iaUdoPur-tN7Ad5tgLfR2EMK2Tx8Lw6CFBdBpS7Ep42AUsVTgGSyCzA66EICN5suhv-E-A2di6gQ</recordid><startdate>20121015</startdate><enddate>20121015</enddate><creator>Fujisawa, Takuya</creator><creator>Miyai, Hiroko</creator><creator>Hironaka, Kohei</creator><creator>Tsukamoto, Toshimasa</creator><creator>Tahara, Kohei</creator><creator>Tozuka, Yuichi</creator><creator>Ito, Masaki</creator><creator>Takeuchi, Hirofumi</creator><general>Elsevier B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121015</creationdate><title>Liposomal diclofenac eye drop formulations targeting the retina: Formulation stability improvement using surface modification of liposomes</title><author>Fujisawa, Takuya ; Miyai, Hiroko ; Hironaka, Kohei ; Tsukamoto, Toshimasa ; Tahara, Kohei ; Tozuka, Yuichi ; Ito, Masaki ; Takeuchi, Hirofumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-6f9d3442517c7b06f1d30317b7f0675bbb73c045088fb1026a805cc672fd84553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>acetates</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - chemistry</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics</topic><topic>calcium</topic><topic>Calcium acetate gradient method</topic><topic>Chemistry, Pharmaceutical</topic><topic>Diclofenac</topic><topic>Diclofenac - administration &amp; dosage</topic><topic>Diclofenac - chemistry</topic><topic>Diclofenac - pharmacokinetics</topic><topic>Drug Stability</topic><topic>encapsulation</topic><topic>Eye drop</topic><topic>Liposome</topic><topic>Liposomes</topic><topic>Ophthalmic Solutions</topic><topic>Particle Size</topic><topic>polyvinyl alcohol</topic><topic>Polyvinyl Alcohol - administration &amp; dosage</topic><topic>Polyvinyl Alcohol - chemistry</topic><topic>Polyvinyl Alcohol - pharmacokinetics</topic><topic>PVA</topic><topic>Rabbits</topic><topic>Retina</topic><topic>Retina - metabolism</topic><topic>Surface Properties</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fujisawa, Takuya</creatorcontrib><creatorcontrib>Miyai, Hiroko</creatorcontrib><creatorcontrib>Hironaka, Kohei</creatorcontrib><creatorcontrib>Tsukamoto, Toshimasa</creatorcontrib><creatorcontrib>Tahara, Kohei</creatorcontrib><creatorcontrib>Tozuka, Yuichi</creatorcontrib><creatorcontrib>Ito, Masaki</creatorcontrib><creatorcontrib>Takeuchi, Hirofumi</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fujisawa, Takuya</au><au>Miyai, Hiroko</au><au>Hironaka, Kohei</au><au>Tsukamoto, Toshimasa</au><au>Tahara, Kohei</au><au>Tozuka, Yuichi</au><au>Ito, Masaki</au><au>Takeuchi, Hirofumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Liposomal diclofenac eye drop formulations targeting the retina: Formulation stability improvement using surface modification of liposomes</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2012-10-15</date><risdate>2012</risdate><volume>436</volume><issue>1-2</issue><spage>564</spage><epage>567</epage><pages>564-567</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>The modifying liposome surface with polyvinyl alcohol or its derivative prevented the liposome aggregation and/or fusion during remote loading process, leading to effective retinal delivery. An efficient liposomal formulation for targeting the retina was produced as an optimal means of distributing therapeutic agents to the retina. Diclofenac was used as a model compound for liposome encapsulation, and the release rate and distribution to the retina were investigated. The calcium acetate gradient method was found to be the optimal method for encapsulating diclofenac into liposomes. Entrapment efficiency using this method was greater than 97%, whereas conventional hydration method achieved 51.3%. The resultant formulation obtained with the gradient method caused aggregation and/or fusion of liposomes. To avoid inhibition of retinal delivery due to the aggregation of the carrier, surface modification was performed simultaneously with the gradient method. The increase in particle size of the liposomal formulation clearly was inhibited for a long time in the presence of polyvinyl alcohol or its derivative. This observation may be explained by surface modification of the liposomes by physisorption or anchoring effect of polymers on the surface of the lipid bilayer. Furthermore, the sustained release profile of the diclofenac formulation was retained after modification. An in vivo animal study revealed that concentration of the accumulated diclofenac in the retina–choroid was enhanced 1.8-fold by surface-modified liposome entrapment compared to that of the unaltered diclofenac solution.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>22828072</pmid><doi>10.1016/j.ijpharm.2012.07.024</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2012-10, Vol.436 (1-2), p.564-567
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_1037886259
source Elsevier
subjects acetates
Animals
Anti-Inflammatory Agents, Non-Steroidal - administration & dosage
Anti-Inflammatory Agents, Non-Steroidal - chemistry
Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics
calcium
Calcium acetate gradient method
Chemistry, Pharmaceutical
Diclofenac
Diclofenac - administration & dosage
Diclofenac - chemistry
Diclofenac - pharmacokinetics
Drug Stability
encapsulation
Eye drop
Liposome
Liposomes
Ophthalmic Solutions
Particle Size
polyvinyl alcohol
Polyvinyl Alcohol - administration & dosage
Polyvinyl Alcohol - chemistry
Polyvinyl Alcohol - pharmacokinetics
PVA
Rabbits
Retina
Retina - metabolism
Surface Properties
title Liposomal diclofenac eye drop formulations targeting the retina: Formulation stability improvement using surface modification of liposomes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T06%3A47%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Liposomal%20diclofenac%20eye%20drop%20formulations%20targeting%20the%20retina:%20Formulation%20stability%20improvement%20using%20surface%20modification%20of%20liposomes&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Fujisawa,%20Takuya&rft.date=2012-10-15&rft.volume=436&rft.issue=1-2&rft.spage=564&rft.epage=567&rft.pages=564-567&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2012.07.024&rft_dat=%3Cproquest_cross%3E1037886259%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-6f9d3442517c7b06f1d30317b7f0675bbb73c045088fb1026a805cc672fd84553%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1037886259&rft_id=info:pmid/22828072&rfr_iscdi=true